- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-07-07, 20:42:31
- Local Time:
- 2025-07-18, 07:15:33
- Last Active:
- 2025-07-07, 23:06:53
Signature:
5% after 1year (8/9) and 71.4% after 3years (5/7).The most effective first-line therapy and retreatment option remains rituximab. The effectivene